BG61595B1 - Използване на креатин фосфат или фосфоенолпирогрозденакиселина за лечение на тумори - Google Patents
Използване на креатин фосфат или фосфоенолпирогрозденакиселина за лечение на тумори Download PDFInfo
- Publication number
- BG61595B1 BG61595B1 BG98825A BG9882594A BG61595B1 BG 61595 B1 BG61595 B1 BG 61595B1 BG 98825 A BG98825 A BG 98825A BG 9882594 A BG9882594 A BG 9882594A BG 61595 B1 BG61595 B1 BG 61595B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- compound
- treatment
- rich
- energy
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9114967A FR2684381B1 (fr) | 1991-12-03 | 1991-12-03 | Composes presentant une liaison amide phosphorique ou une liaison phosphate d'enol pour leur application en tant que substance therapeutiquement active. |
| PCT/FR1992/001118 WO1993010792A1 (fr) | 1991-12-03 | 1992-12-01 | Utilisation de la creatine phosphate ou de l'acide phosphoenol pyruvique pour le traitement des tumeurs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG98825A BG98825A (bg) | 1995-05-31 |
| BG61595B1 true BG61595B1 (bg) | 1998-01-30 |
Family
ID=9419629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG98825A BG61595B1 (bg) | 1991-12-03 | 1994-06-01 | Използване на креатин фосфат или фосфоенолпирогрозденакиселина за лечение на тумори |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5219846A (cs) |
| EP (1) | EP0614366B1 (cs) |
| JP (1) | JP3437574B2 (cs) |
| KR (1) | KR100235893B1 (cs) |
| AT (1) | ATE142499T1 (cs) |
| AU (1) | AU3260093A (cs) |
| BG (1) | BG61595B1 (cs) |
| CA (1) | CA2124793C (cs) |
| CZ (1) | CZ284966B6 (cs) |
| DE (1) | DE69213757T2 (cs) |
| DK (1) | DK0614366T3 (cs) |
| ES (1) | ES2094522T3 (cs) |
| FR (1) | FR2684381B1 (cs) |
| GR (1) | GR3021876T3 (cs) |
| HU (1) | HU216826B (cs) |
| LV (1) | LV11821B (cs) |
| RO (1) | RO115784B1 (cs) |
| RU (1) | RU2097040C1 (cs) |
| SK (1) | SK280785B6 (cs) |
| UA (1) | UA41285C2 (cs) |
| WO (1) | WO1993010792A1 (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994016712A1 (en) * | 1993-01-27 | 1994-08-04 | Amira, Inc. | Creatine phosphate, creatine phosphate analogs, and uses therefor |
| AU6165894A (en) * | 1993-01-28 | 1994-08-15 | Trustees Of The University Of Pennsylvania, The | Use of creatine or analogs for the manufacture of a medicament for inhibiting tumor growth |
| US5714361A (en) * | 1994-02-14 | 1998-02-03 | Indiana University Foundation | Phosphatase/phosphodiesterase enzyme inhibitors and methods |
| US5627172A (en) * | 1994-03-04 | 1997-05-06 | Natural Supplement Association, Incorporated | Method for reduction of serum blood lipids or lipoprotein fraction |
| DE19537494C2 (de) * | 1995-09-25 | 1997-10-02 | Desitin Arzneimittel Gmbh | Kreatin zum Schutz von neuralem Gewebe |
| DE19653225A1 (de) * | 1996-12-20 | 1998-06-25 | Sueddeutsche Kalkstickstoff | Kreatin-pyruvate und Verfahren zu deren Herstellung |
| DE10116589A1 (de) * | 2001-04-03 | 2002-10-10 | Wulf Droege | Anwendung von Kreatin zur Minderung von oxidativem Stress |
| RU2309747C2 (ru) * | 2002-09-18 | 2007-11-10 | Михаил Владимирович Кутушов | Применение 2-хлорэтилфосфоновой кислоты и ее солей в качестве противоопухолевого средства |
| WO2004100885A2 (en) * | 2003-05-09 | 2004-11-25 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treating cancer |
| RU2354645C1 (ru) * | 2007-11-21 | 2009-05-10 | Закрытое Акционерное Общество "Вертекс" | Амиды креатина, способ их получения, средство, обладающее нейропротекторным действием |
| US8350077B2 (en) | 2008-12-24 | 2013-01-08 | Vertex Closed Joint Stock Company | Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity |
| RU2428414C2 (ru) | 2009-11-03 | 2011-09-10 | Закрытое Акционерное Общество "Вертекс" | Способ получения амидов креатина |
| WO2016007622A1 (en) * | 2014-07-09 | 2016-01-14 | Sidra Medical and Research Center | Imaging of creatine kinase enzyme expression in cancerous tissues |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8200252L (sv) * | 1982-01-18 | 1983-07-19 | Pharmacia Ab | Farmaceutisk komposition |
| IT1214598B (it) * | 1985-04-17 | 1990-01-18 | Schiapparelli Farma | Uso terapeutico della fosfocreatina. |
| IT1191639B (it) * | 1985-11-11 | 1988-03-23 | Schiapparelli Farma | Composizione farmaceutica contenente fosfocreatina e metodo per preparla |
| US4874882A (en) * | 1986-03-25 | 1989-10-17 | Ube Industries, Ltd. | Process for preparing monosodium phosphoenolpyruvate |
| US4769318A (en) * | 1986-06-03 | 1988-09-06 | Ube Industries, Ltd. | Additive solution for blood preservation and activation |
-
1991
- 1991-12-03 FR FR9114967A patent/FR2684381B1/fr not_active Expired - Lifetime
- 1991-12-20 US US07/811,058 patent/US5219846A/en not_active Expired - Lifetime
-
1992
- 1992-12-01 RU RU9294030808A patent/RU2097040C1/ru not_active IP Right Cessation
- 1992-12-01 HU HU9401656A patent/HU216826B/hu not_active IP Right Cessation
- 1992-12-01 SK SK683-94A patent/SK280785B6/sk not_active IP Right Cessation
- 1992-12-01 CZ CZ941343A patent/CZ284966B6/cs not_active IP Right Cessation
- 1992-12-01 EP EP93901806A patent/EP0614366B1/fr not_active Expired - Lifetime
- 1992-12-01 AT AT93901806T patent/ATE142499T1/de active
- 1992-12-01 AU AU32600/93A patent/AU3260093A/en not_active Abandoned
- 1992-12-01 CA CA002124793A patent/CA2124793C/en not_active Expired - Fee Related
- 1992-12-01 RO RO94-00930A patent/RO115784B1/ro unknown
- 1992-12-01 KR KR1019940701870A patent/KR100235893B1/ko not_active Expired - Fee Related
- 1992-12-01 WO PCT/FR1992/001118 patent/WO1993010792A1/fr active IP Right Grant
- 1992-12-01 JP JP50989193A patent/JP3437574B2/ja not_active Expired - Fee Related
- 1992-12-01 UA UA94005324A patent/UA41285C2/uk unknown
- 1992-12-01 ES ES93901806T patent/ES2094522T3/es not_active Expired - Lifetime
- 1992-12-01 DE DE69213757T patent/DE69213757T2/de not_active Expired - Lifetime
- 1992-12-01 DK DK93901806.5T patent/DK0614366T3/da active
-
1994
- 1994-06-01 BG BG98825A patent/BG61595B1/bg unknown
-
1996
- 1996-12-04 GR GR960403287T patent/GR3021876T3/el unknown
-
1997
- 1997-02-05 LV LVP-97-18A patent/LV11821B/lv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69213757T2 (de) | 1997-04-03 |
| DK0614366T3 (da) | 1996-11-25 |
| EP0614366A1 (fr) | 1994-09-14 |
| HUT68876A (en) | 1995-08-28 |
| SK280785B6 (sk) | 2000-07-11 |
| CA2124793C (en) | 2005-09-20 |
| FR2684381B1 (fr) | 1995-05-05 |
| HU216826B (hu) | 1999-09-28 |
| EP0614366B1 (fr) | 1996-09-11 |
| AU3260093A (en) | 1993-06-28 |
| CA2124793A1 (en) | 1993-06-10 |
| RU94030808A (ru) | 1996-10-20 |
| JPH07501534A (ja) | 1995-02-16 |
| KR100235893B1 (ko) | 1999-12-15 |
| FR2684381A1 (fr) | 1993-06-04 |
| UA41285C2 (uk) | 2001-09-17 |
| ATE142499T1 (de) | 1996-09-15 |
| GR3021876T3 (en) | 1997-03-31 |
| SK68394A3 (en) | 1995-03-08 |
| JP3437574B2 (ja) | 2003-08-18 |
| WO1993010792A1 (fr) | 1993-06-10 |
| RO115784B1 (ro) | 2000-06-30 |
| CZ284966B6 (cs) | 1999-04-14 |
| CZ134394A3 (en) | 1994-12-15 |
| DE69213757D1 (de) | 1996-10-17 |
| RU2097040C1 (ru) | 1997-11-27 |
| BG98825A (bg) | 1995-05-31 |
| ES2094522T3 (es) | 1997-01-16 |
| LV11821B (en) | 1997-12-20 |
| LV11821A (lv) | 1997-08-20 |
| HU9401656D0 (en) | 1994-09-28 |
| US5219846A (en) | 1993-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9814724B2 (en) | Antitumor effect potentiator and antitumor agent | |
| US6489312B1 (en) | Pharmaceutical formulations comprising aminoalkyl phosphorothioates | |
| BG61595B1 (bg) | Използване на креатин фосфат или фосфоенолпирогрозденакиселина за лечение на тумори | |
| US12325705B2 (en) | Small molecules for the treatment of primary cancer and cancer metastasis | |
| JP2005506294A (ja) | テガフル、ウラシル、フォリン酸、パクリタキセルおよびカルボプラチンの投与による腫瘍の治療方法および剤形 | |
| TW202320758A (zh) | 組合 | |
| WO2023114871A1 (en) | Use of combination therapy for treating cancer | |
| EP1463504A1 (en) | Compositions comprising epothilones and their use for the treatment of the carcinoid syndrome | |
| US6987100B2 (en) | Pharmaceutical compositions for treating bone lesions in multiple myeloma | |
| JP2004504346A (ja) | 骨転移の治療におけるリン酸エストラムスチンの使用 | |
| PT1757283E (pt) | Potenciador do efeito antitumoral, agente antitumoral e método para a terapia do cancro | |
| US20040138207A1 (en) | Antitumor agents | |
| AU2002366531B2 (en) | Compositions comprising epothilones and their use for the treatment of carcinoid syndrome | |
| US20040254123A1 (en) | Malignant cell differentiation inducer compositions and utilization of the same | |
| Marshall et al. | Hepsulfam distribution in blood, plasma and cerebrospinal fluid of baboons | |
| HK1240937A1 (en) | Small molecules for the treatment of primary cancer and cancer metastasis | |
| HK1152247B (en) | Methods of treatment employing prolonged continuous infusion of belinostat | |
| HK1152247A1 (en) | Methods of treatment employing prolonged continuous infusion of belinostat | |
| JPH08277223A (ja) | 高カルシウム血症治療のための薬剤 | |
| JP2001261573A (ja) | 腫瘍転移抑制剤 |